Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Johnson

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
International Journal of Tissue Reactions|January 1, 1991
Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitroJ S Nixon, K M Bottomley, M J Broadhurst, et al.
Biochemistry|September 24, 1999
Kinetic, stereochemical, and structural effects of mutations of the active site arginine residues in 4-oxalocrotonate tautomeraseT K Harris, R M Czerwinski, W H Johnson, et al.
Journal of Medicinal Chemistry|April 1, 1990
Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 1. Initial structure-activity relationshipsR D Youssefyeh, E Magnien, T D Lee, et al.
Journal of Reproduction and Fertility|November 1, 1990
Failure to maintain interspecific pregnancy after transfer of Dall's sheep embryos to domestic ewesB C Buckrell, C J Gartley, K G Mehren, et al.
Journal of Medicinal Chemistry|October 1, 1990
The development of a novel series of (quinolin-2-ylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 3. Structural variation of the acidic side chain to give antagonists of enhanced potencyR A Galemmo, W H Johnson, K S Learn, et al.
Journal of Medicinal Chemistry|April 1, 1990
Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 2. Effects of an additional phenyl ring on receptor affinityF C Huang, R A Galemmo, W H Johnson, et al.
Pediatric Cardiology|May 9, 2001
Iodixanol pharmacokinetics in childrenW H Johnson, T R Lloyd, B E Victorica, et al.
Journal of Medicinal Chemistry|May 11, 1991
Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 4. Addition of chromone moiety enhances leukotriene D4 receptor binding affinityF C Huang, R A Galemmo, G B Poli, et al.
British Journal of Pharmacology|June 1, 1997
Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivoE J Lewis, J Bishop, K M Bottomley, et al.
The Biochemical Journal|April 15, 1997
Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitorsK M Bottomley, N Borkakoti, D Bradshaw, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
International Journal of Tissue Reactions|January 1, 1991
Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitroJ S Nixon, K M Bottomley, M J Broadhurst, et al.
Biochemistry|September 24, 1999
Kinetic, stereochemical, and structural effects of mutations of the active site arginine residues in 4-oxalocrotonate tautomeraseT K Harris, R M Czerwinski, W H Johnson, et al.
Journal of Medicinal Chemistry|April 1, 1990
Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 1. Initial structure-activity relationshipsR D Youssefyeh, E Magnien, T D Lee, et al.
Journal of Reproduction and Fertility|November 1, 1990
Failure to maintain interspecific pregnancy after transfer of Dall's sheep embryos to domestic ewesB C Buckrell, C J Gartley, K G Mehren, et al.
Journal of Medicinal Chemistry|October 1, 1990
The development of a novel series of (quinolin-2-ylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 3. Structural variation of the acidic side chain to give antagonists of enhanced potencyR A Galemmo, W H Johnson, K S Learn, et al.
Journal of Medicinal Chemistry|April 1, 1990
Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 2. Effects of an additional phenyl ring on receptor affinityF C Huang, R A Galemmo, W H Johnson, et al.
Pediatric Cardiology|May 9, 2001
Iodixanol pharmacokinetics in childrenW H Johnson, T R Lloyd, B E Victorica, et al.
Journal of Medicinal Chemistry|May 11, 1991
Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 4. Addition of chromone moiety enhances leukotriene D4 receptor binding affinityF C Huang, R A Galemmo, G B Poli, et al.
British Journal of Pharmacology|June 1, 1997
Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivoE J Lewis, J Bishop, K M Bottomley, et al.
The Biochemical Journal|April 15, 1997
Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitorsK M Bottomley, N Borkakoti, D Bradshaw, et al.
Pageof 14